A new clinical trial shows that drinking a beverage containing of fragmented Lactobacillus amylovorus CP1563 (CP1563) 200 mg daily for 12 weeks significantly reduces body fat and improves glucose and lipid measurements in obese people with a BMI of 25-30 kg/m2. Significant reductions were seen in triglycerides, total cholesterol and low-density lipoprotein (LDL) cholesterol levels as well as diastolic blood pressure.
The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2024 NatMed. Commercial distribution or reproduction prohibited. NatMed is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.
